Skip To Main Content
Riya Debbarma on Muck Rack

Riya Debbarma

As seen in: AIChE Journal, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Riya

Contact Riya, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Image analysis method for measurement and prediction of intra‐matrix IgG diffusion

|
By Riya Debbarma, Michael R. Ladisch
| AIChE Journal Verified
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request. Supporting Information Filename Description btpr70085-sup-0001-Supinfo.docxWord 2007 document , 1.8 MB Data S1: Supplementary Information. btpr70085-sup-0002-Video.mp4MPEG-4 video, 185.4 MB Video S1: Procedure for image analysis: step-by-step explanation and example. REFERENCES 1.
Open in Who Shared Issue with article?

Imaging of Intra-Matrix IgG Diffusion as an Indicator of Age-Related Vitreous Changes

|
By Riya Debbarma, Diana Gutierrez, Kendra A Erk, Hara Koo
| dx.doi.org
Open in Who Shared Issue with article?

Hyaluronic Acid Matrices for In Situ Measurement of Protein Diffusion Coefficients

|
By Morrissey College, Kayla Hinton, Mazin Hakim, Riya Debbarma
| Wiley Online Library Verified
ECM extracellular matrix HA hyaluronic acid ISM in vitro Subcutaneous Matrix SEC size exclusion chromatography SQ subcutaneous 1 Introduction Monoclonal antibodies (mAbs) constitute two-thirds of current biopharmaceutical protein products with nearly 1200 antibodies at various stages of testing, worldwide, as of November 2022 [1]. In the United States, there are 122 mAbs approved by the Food and Drug Administration (FDA) as of June 2022 [2].
Open in Who Shared Issue with article?
See all 3 articles